Stocks
ResMed (RMD) EBITDA margin US GAAP (year values) |
|||||||||
| FY2023 | FY2024 | FY2025 | FY2026 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 32.2% | 32.7% | 37.2% | 38.0% | 38.0% | 38.0% | ||
| Changes by years, y/y, % | -1pp | +1pp | +4pp | +1pp | 0pp | +1.9% | |||
ResMed. EBITDA margin, %
ResMed. EBITDA margin, changes, pp
ResMed (RMD) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2026Q2 | FY2026Q3 | FY2026Q3 | FY2026Q4 | FY2026Q4 | LTM ? | |||
| EBITDA margin, % | ? | 39.8% | 40.8% | 40.8% | 33.7% | 33.7% | 38.0% | |
| Changes by years, y/y, % | +2pp | +4pp | +4pp | -6pp | -6pp | |||
| Changes by quarters, q/q, % | +2pp | +1pp | 0pp | -7pp | 0pp | |||
